Full Committee Hearing with Health Insurance CEOs

Health Care Costs and Drug PricingHouse Ways and Means · 2026-01-22 · 119th Congress
The House Ways and Means Committee convened this hearing to question the chief executives of major health insurers about the drivers of rising health insurance premiums, deductibles, and denials, and to examine consolidation, prior authorization, and Medicare Advantage practices. Begins at 0:15:56
Transcript
Highlights

Title

Health insurance CEOs testify on rising health care costs and ACA subsidies

Purpose

The House Ways and Means Committee convened this hearing to question the chief executives of major health insurers about the drivers of rising health insurance premiums, deductibles, and denials, and to examine consolidation, prior authorization, and Medicare Advantage practices. Witnesses included the CEOs of UnitedHealth Group, CVS Health, Elevance Health, Cigna, and Ascendiun (Blue Shield of California), plus small-business owner and breast-cancer survivor ReShonda Young, testifying amid a partisan fight over the expiring enhanced ACA premium tax credits. Chairman Smith framed the hearing around insurer accountability and consolidation, while Ranking Member Neal pressed for extending the ACA subsidies. Begins at0:15:56

Who spoke

Chairman Jason Smith (R-MO)0:15:56: Opened citing $27,000 average family premiums and 80% ACA premium growth over a decade0:17:38, later revealed a personal health crisis and accused insurers of putting "profits above patients"2:15:22, and used a show-of-hands exercise to establish that the same companies own insurance, providers, and PBMs1:01:26.

Ranking Member Richard Neal (D-MA)0:24:32: Blamed Republicans for letting enhanced ACA tax credits expire and refusing to extend them0:24:54, cited Massachusetts's near-universal coverage model as a bipartisan success1:10:05, and argued Republicans lack an alternative to the ACA0:26:32.

Stephen Hemsley, CEO, UnitedHealth Group0:31:26: Said hospital and drug spending has risen three times the inflation rate0:32:24, announced UnitedHealth will voluntarily forgo and rebate ACA individual-plan profits this year0:35:30, and said the company negotiated nearly $300 billion in savings last year0:33:41.

David Joyner, Chairman & CEO, CVS Health0:36:36: Said 77% of prior-authorization requests are approved in near real time, down from 3 hours to 34 minutes for medication approvals0:38:12, and touted biosimilar competition saving $1.5 billion0:39:02; later conceded charging $6,600/month for a generic drug available for $55 was not "logical"3:31:59.

Gail Boudreaux, President & CEO, Elevance Health0:41:43: Said prior authorization applies to only about 3% of claims and 400+ services were removed from requirements since 20240:43:06; said hospital spending rose nearly 10% in 2023 and 2024, the fastest pace in three decades0:44:14.

David Cordani, President, CEO & Chairman, The Cigna Group0:47:02: Said prescription drug prices have risen more than three times inflation over 30 years0:48:19 and a hospital stay's cost is up 220% since 20000:49:45; confirmed Cigna's new no-rebate, no-spread-pricing PBM will cut earnings by $500–600 million next year2:05:15.

Paul Markovich, President & CEO, Ascendiun (Blue Shield of California)0:52:01: Called the health system "bankrupting and failing us"0:52:35 and said Blue Shield capped its profit at 2% of revenue, returning over $800 million to customers0:55:12; bluntly answered "no" when asked if insurers are doing what's needed to lower costs1:05:50.

ReShonda Young, small-business owner and breast cancer survivor, Waterloo, Iowa0:56:46: Testified her ACA premium would jump from $94 to $592/month without enhanced tax credits, forcing her onto a bronze plan with a deductible rising from $1,500 to $7,5000:57:420:58:09; said the credits let her focus on cancer treatment rather than affordability0:59:07.

Rep. Lloyd Doggett (D-TX)1:19:08: Criticized GAO fraud claims as targeting brokers, not patients1:19:36, cited reinstatement of 850 suspended insurance brokers1:20:33, and raised a constituent surgeon (Dr. Elizabeth Potter) denied in-network status by United1:22:20.

Rep. Adrian Smith (R-NE)1:23:33: Cited a study that 35% of ACA enrollees logged no claims in 20241:25:53 and pressed Cordani on Cigna's $8.6 billion in shareholder returns despite a 40% premium increase in one state1:27:51.

Rep. Mike Thompson (D-CA)1:30:02: Highlighted alleged Medicare Advantage overbilling of veterans whose care is provided by the VA1:31:54 and pressed all CEOs on AI-driven prior-authorization denials1:33:30.

Rep. Mike Kelly (R-PA)1:36:39: Promoted his Improving Seniors' Timely Access to Care Act, noting 240+ co-sponsors and CVS's endorsement1:38:20.

Rep. John Larson (D-CT)1:41:53: Pressed Markovich on the "fraud" framing of unused ACA claims (~18% in California)1:42:17 and sought to submit a Maryland court opinion on DOGE's access to Social Security data1:43:25.

Rep. Kevin Hern (R-OK)1:47:13: Cited MedPAC data showing Medicare Advantage costs 120% of fee-for-service versus a 95% design target1:47:43, and asked Hemsley how to redesign MA incentives1:49:39.

Rep. Brian Fitzpatrick (R-PA)1:52:56: Asked Young what could make health care more accessible1:55:05 and had CEOs each name one reform, with Hemsley citing consensus on outcomes-based incentives1:56:55.

Rep. Darin LaHood (R-IL)1:57:55: Asked Hemsley why United, as the largest purchaser of hospital/physician services, still cannot lower prices in negotiations1:59:39, citing market concentration limits2:00:10.

Rep. Linda Sánchez (D-CA)2:03:04: Pressed Hemsley, Cordani, and Boudreaux individually on whether they would rebate profits to offset ACA premium hikes; only Hemsley said yes2:04:112:04:452:06:41; described her own denied in-home physical therapy after knee surgery2:07:45.

Rep. Jodey Arrington (R-TX)2:08:45: Noted federal health spending rose from $19 billion (1975) to nearly $2 trillion, a third of the budget2:09:41, and pressed on 6.5 million allegedly ineligible ACA enrollees2:11:23.

Rep. Greg Murphy (R-NC), a physician2:14:32: Said it took him eight denials over 18 months to get a needed medication through CVS2:16:18 and cited a 70% vs. 3% MA/fee-for-service disparity in secondary hyperparathyroidism diagnoses2:17:47; secured yes/no commitments on Trump Rx deductible credit2:19:02.

Rep. Terri Sewell (D-AL)3:01:04: Described Hale County Hospital's billing disputes with United Healthcare, including retroactive denials and misclassified inpatient/observation status3:02:35, and cited 3.2 million MA prior-authorization denials in 2023, 81.7% overturned on appeal3:04:05.

Rep. Ron Estes (R-KS)3:06:57: Cited 26.6% premium hikes and 14 Kansas counties with only one insurer3:07:27, and questioned CEOs on medical loss ratio (MLR) limits3:09:42.

Rep. Lloyd Smucker (R-PA)3:12:59: Presented a chart correlating insurer stock price growth since 2014 with rising premiums3:14:27 and pressed Hemsley and Boudreaux on whether consolidation has lowered costs3:16:033:17:27.

Rep. Judy Chu (D-CA)3:18:16: Highlighted a $498/month increase for Young's coverage and Covered California data on bronze-plan cost-sharing gaps3:18:45; pressed Hemsley and Markovich on contraceptive coverage violations and vaccine coverage amid RFK Jr.'s hepatitis B guidance change3:20:453:22:20.

Rep. Bill Hearn (R-... )3:24:07: Raised a constituent's $10,000 out-of-network Mayo Clinic bill and 60% premium spike3:26:46, and pressed Boudreaux and Cordani on transparency3:25:253:27:38.

Rep. David Kustoff (R-TN)3:29:31: Cited a Wall Street Journal report that CVS and Cigna charged $6,600/month for a $55 generic cancer drug3:29:57, prompting Joyner's admission the pricing was "a lot"3:31:59.

Rep. Gwen Moore (D-WI)3:34:44: Asked CEOs directly whether vertical integration and CEO pay contribute to costs, receiving no affirmative answers3:36:24; cited a constituent needing two brain stents who faced hours-long prior-authorization delays3:39:39.

Rep. Brian Fitzpatrick (R-PA), second round3:40:24: Cited three insurers controlling 40% of the commercial/MA market and 80% of PBM share3:41:17, and secured no objections to the bipartisan Patients Deserve Price Tags Act3:42:11.

Rep. Carol Miller (R-WV)3:45:51: Cited data that brand drugs are only 10 cents of every premium dollar versus 16 cents for administrative overhead and profit3:46:21, and pressed Joyner on Medicare billing disparities for a leukemia drug ranging $75–$8,0003:48:53.

Rep. Don Beyer (D-VA)3:51:26: Compared U.S. health spending (18.5–20% of GDP, 78-year life expectancy) unfavorably to Switzerland, Denmark, and Italy3:52:10; questioned Boudreaux on Anthem's mental-health parity settlement3:55:15.

Rep. Claudia Tenney (R-NY)3:57:03: Described her family business's $36,000 family health plan cost with $16,000 self-insured3:58:03, and questioned Hemsley on whether PBM rebate pass-through actually lowers MLR-calculated premiums4:00:11.

Rep. Beth Van Duyne (R-FL), misattributed in transcript as "Beth Vany"4:03:24: Recounted her infant daughter's denied eye surgery4:03:49 and cited GAO findings of $21 billion in unverified ACA tax credits4:06:10.

Rep. Mike Schneider (D-IL)4:08:44: Tied Medicaid cuts and reduced vaccine recommendations to rising uncompensated care costs, getting all five CEOs to agree uncompensated care raises premiums4:11:274:12:42; cited a measles case surge from 59 (2023) to 2,242 (2025)4:13:07.

Rep. Michelle Fischbach (R-MN)4:14:20: Pressed Hemsley on rural Minnesota premium increases and network narrowing4:15:034:17:48, and asked Cordani about rural ambulance reimbursement rates4:18:24.

Rep. Blake Moore (R-UT)4:20:19: Questioned Cordani on Utah cost outcomes under self-funded employer plans4:22:07 and pressed Hemsley on the sustainability of the ACA profit-rebate pledge4:24:53.

Rep. Guy Reschenthaler / "Mr. Petta" (R-PA)4:26:10: Promoted the bipartisan Real Health Providers Act targeting "ghost networks" in Medicare Advantage directories4:27:42, getting general support from all CEOs4:28:384:29:24.

Rep. Randy Feenstra (R-IA)4:30:41: Asked whether the ACA created incentives to reduce costs versus just manage them4:32:51, and raised rural Iowa's single-carrier problem4:33:49.

Rep. Aaron Bean (R-FL)4:36:06: Invoked Florida's managed-care Medicaid model4:37:31 and criticized insurers' use of MLR subsidiary structuring4:39:06.

Rep. Stacey Plaskett (D-VI)4:41:15: Noted the U.S. Virgin Islands lacks an ACA exchange, leaving many residents uninsured4:44:12, and discussed value-based care with Hemsley and Cordani4:45:394:46:12.

Rep. Mike Carey (R-OH), referred to as "Mr. Kerry"4:48:03: Introduced the CARE Act on ambulance treat-in-place payment models with bipartisan co-sponsor Doggett, receiving yes answers from all CEOs4:50:24.

Rep. Jefferson Shreve / "Mr. Yakam" (R-IN)4:53:14: Cited Indiana's $25,000 average premiums and pressed Hemsley on rural provider reimbursement and access4:53:364:54:34.

Rep. Steven Horsford (D-NV)4:58:40: Invited Young to speak directly to viewers about the human cost of unaffordable care4:59:36 and questioned Hemsley and Joyner on Medicare Advantage transparency5:03:22.

Rep. Max Miller (R-OH)5:06:09: Cited Ohio data that one in five residents struggle to pay medical bills5:06:36 and secured "no" answers from all CEOs on whether inefficient prior authorizations improve affordability5:09:52.

Rep. Nathaniel Moran / "Mr. Marine" (R-TX)5:12:17: Cited a roughly 1,000% rise in health insurer stock prices from 2014–2024 against a 100% rise in ACA premiums5:15:00, challenging CEOs to justify the disparity.

Key moments

Chairman Smith's show-of-hands exercise established that the largest insurers also own medical providers, PBMs, and are publicly traded with shareholder obligations1:01:26.

Hemsley announced UnitedHealth will forgo and rebate its 2025 ACA individual-market profits, while Cordani and Boudreaux declined similar commitments, saying they lost money on ACA exchanges2:04:112:04:452:06:41.

Rep. Kustoff cited a Wall Street Journal report that CVS and Cigna charged $6,600/month for a generic cancer drug (imatinib) available for $55; Joyner conceded "I completely agree, it's a lot"3:29:573:31:59.

Chairman Smith described personal experience needing eight denials over 18 months to obtain a medication via CVS despite being a physician and member of Congress2:15:222:16:18.

Markovich was the only CEO to answer "no" when asked whether his company is doing what's needed to lower costs, and separately said Ascendiun/Blue Shield capped profit at 2% of revenue1:05:500:55:12.

Rep. Moran presented data showing health insurer stock prices rose roughly 1,000% from 2014–2024 while ACA premiums rose about 100% over the same period, and no CEO disputed the figures5:15:00.

Rep. Sewell detailed Hale County Hospital's billing disputes with United Healthcare (incorrect coding, retroactive denials, misclassified visits) and cited 81.7% of denied MA prior authorizations being overturned on appeal3:02:353:04:05.

Cordani confirmed Cigna's new no-rebate, no-spread PBM offering will reduce earnings by $500–600 million next year, while noting the ACA exchange represents only about 1% of Cigna's business [2:05:15, 0:56:42-adjacent 2:04:57].

Rep. Hern cited MedPAC findings that Medicare Advantage costs 120% of fee-for-service versus its original 95% design target, and warned the Medicare trust fund could be exhausted in six and a half years1:47:431:49:39.

Young testified her monthly ACA premium would rise from $94 to $592 upon expiration of enhanced tax credits, forcing a switch to a bronze plan with deductible rising from $1,500 to $7,5000:57:420:58:09.

Metadata

CommitteeHouse Ways and Means
Chamber / CongressHouse · 119th Congress
Date2026-01-22
TypeHearing
Witnesses
Mr. David Joyner — Chairman and CEO, CVS Health
Mr. Stephen Hemsley — CEO, UnitedHealth Group
Ms. Gail Boudreaux — President and CEO, Elevance Health
Mr. David Cordani — President, CEO, and Chairman of the Board, The Cigna Group
Mr. Paul Markovich — President and CEO, Ascendiun
Ms. ReShonda Young — Resident of Waterloo, Iowa and Owner, TnK Health and Nutrition
Videoyoutube
Transcript812 caption blocks · 41,324 words · 5:17:50 runtime
EventCongress.gov 118887